Synaptogenix Inc (SNPX)

[Cyosol]

100 patients may seem smaller at first, but you have to keep it mind that not only did the previous trial have 3 patient groups (20, 40, placebo), but some of them were also on Memantine.

If you look at the most recent presentation, only 25 non-memantine completers were receiving either the 20 dose or placebo.

So while there are less patients this time around, there are significantly more non-memantine patients per patient group.